Global Non Invasive Prenatal Testing (NIPT) Market is estimated to reach USD 7.3 billion by 2024 from USD 3.9 billion in 2019, at a CAGR of 13.5% during the forecast period.

The non-invasive prenatal testing (NIPT) market is growing at a rapid pace, due to the increasing prevalence of chromosomal abnormalities, technological advancements in the field of prenatal testing, and growing awareness among pregnant women about the importance of prenatal screening. The non-invasive prenatal testing (NIPT) is a screening test used to detect chromosomal abnormalities in fetuses. It provides a safe and reliable testing option for pregnant women who are at an increased risk of having a baby with a chromosomal abnormality.

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=145607690

The rising demand for non-invasive prenatal testing is driven by several factors such as increasing awareness among pregnant women, growing incidence of chromosomal disorders, and technological advancements. The increasing prevalence of chromosomal abnormalities in newborns is a major factor driving the global non-invasive prenatal testing market.

The growing awareness among pregnant women about the importance of prenatal screening and the availability of cost-effective screening tests are other factors contributing to the growth of the market. Additionally, technological advancements in the field of prenatal testing, such as the development of non-invasive prenatal testing kits, are expected to further boost the growth of the non-invasive prenatal testing market.

Get Free 10% Customization on this Report:

https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=145607690

Key Market Players

The prominent players in the Non Invasive Prenatal Testing (NIPT) Market are Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), GE Healthcare (US), BGI (China), Agilent Technologies, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), PerkinElmer Inc. (US), Laboratory Corporation of America Holdings (US), Natera, Inc. (US), and Yourgene Health (UK)

The research report categorizes the global NIPT market into the following segments and subsegments:

By Product

  • Products
  • Consumables
  • Assay Kits & Reagents
  • Disposables
  • Instruments
  • NGS Systems
  • PCR Instruments
  • Microarrays
  • Ultrasound Devices
  • Other Instruments
  • Services

Note: Other instruments include centrifuges, UV systems, incubators, and microscopes.

By Method

  • Ultrasound Detection
  • Biochemical Screening Tests
  • Cell-free DNA in Maternal Plasma Tests

By Application

  • Trisomy
  • Microdeletion Syndrome
  • Other Applications

By End User

  • Diagnostic Laboratories
  • Hospitals

By Region

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Rest of Europe (RoE)
  • Asia
  • Rest of the World (RoW)

Recent Developments:

  • BGI and Eluthia (Germany) launched the NIFTY test (non-invasive prenatal test), under the brand name PreviaTest in Germany.
  • Illumina expanded its NIPT platform with the launch of VeriSeq NIPT Solution v2.
  • Illumina and Pacific Biosciences signed an agreement for Illumina to acquire Pacific Biosciences. This acquisition will allow Illumina to strengthen its sequencing solutions platform with accurate long-read sequencing capabilities.
  • Agilent Technology acquired Multiplicom N.V. (Belgium) in order to create comprehensive offerings for next-generation sequencing solutions. Multiplicom develops and commercializes molecular diagnostic solutions which are useful in the identification of congenital defects early in pregnancy and other genetic diseases

Key Questions Addressed by the Report

  • Where will all these developments take the industry in the mid to long-term?
  • What types of annual and multi-year partnerships are NIPT product and service companies exploring?
  • Which are the key players in the market and how intense is the competition?
  • Which are the recent contracts and agreements key players have signed?
  • What are the recent trends affecting NIPT product and service providers?

Get Free Customization @ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=145607690

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Shelly Singh

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: +1-888-600-6441

Email: sales@marketsandmarkets.com